Bringing together clinicians and researchers in the UK working on frontotemporal dementia and associated disorders.
FTDUK is co-ordinated by Professor Jonathan Rohrer (University College London), Professor James Rowe (University of Cambridge), Dr Kathryn Bowles (University of Edinburgh) and Dr Jenna Gregory (University of Aberdeen).
We run an Early Career Researcher prize for FTD researchers – this is open to any researcher who is a research assistant, PhD student or postdoctoral researcher within 5 years of completion of their PhD.
We have been running FTD UK since 2011 and after an absence during the Covid pandemic we returned in 2023 to run our 10th meeting. The meeting remains free to attend and will be in UCL this year in May – please register by clicking the link above.
We are very thankful to Alzheimer’s Research UK and the Guarantors of Brain who have kindly helped to fund the event each year through conference grants, and to the Alzheimer’s Society who have funded the Early Career Researcher Prize awards.
2026 – 13th Annual Meeting – London – 29th May
| 9.30am | Registration | |
| 10.00am | Welcome to the meeting and introduction | |
| 10.10am | Social determinants of long-term clinical outcomes in FTLD syndromes | Anna Dreyer (University of Cambridge) |
| 10.30am | Large-scale genome-wide analyses on the full clinical spectrum of FTD | Lianne Reus (UCL/Amsterdam) |
| 10.50am | Inflammatory and synaptic pathology in FTLD | Annelies Quaegebeur (University of Cambridge) |
| 11.10am | Coffee break | |
| 11.40am | Distinct mechanistic pathways of early tauopathy revealed by MAPT mutations | Martha Foiani (UCL) |
| 12.00pm | Toxicity of MAPT 4R RNA contributes to motor neuron degeneration in ALS | Hamish Crerar (King's College London) |
| 12.20pm | Profiling astrocyte-vasculature alterations across tauopathies | Paula Beltran Lobo (University of Edinburgh) |
| 12.40pm | Lunch | |
| 1.40pm | Targeting TDP-43 Associated Neurodegenerative Diseases with vectorized antibodies technology: current state and future perspectives | Olga Uspenskaya (VectorY Therapeutics) |
| 2.00pm | Update on current sporadic and genetic FTD therapeutic trials | Alex Murley (University of Cambridge); Sophie Farley (UCL) |
| 2.20pm | UK and international Initiatives in FTD: International PPA caregiver survey study; GENFI; ON-FIRE; UK Dementia Trials Network | Chris Hardy (UCL); Amelia Blesius (UCL); Maura Malpetti (University of Cambridge); Cath Mummery (UCL) |
| 3.00pm | Coffee break | |
| 3.30pm | Alzheimer's Society ECR prizes - introduction and award | |
| 3.35pm | Basic Science Prize for Early Career UK FTD Researcher sponsored by the Alzheimer's Society | |
| 3.45pm | Clinical Science Prize for Early Career UK FTD Researcher sponsored by the Alzheimer's Society | |
| 3.55pm | Summary | |
| 4.00pm | Finish |